Randomized comparison of monotherapy (risperidone, quetiapine, or olanzapine) versus combination therapy (risperidone, quetiapine, or olanzapine + divalproex [valproate semisodium]) in the management of dementia with agitation: a pilot comparison of two standard therapies.

Trial Profile

Randomized comparison of monotherapy (risperidone, quetiapine, or olanzapine) versus combination therapy (risperidone, quetiapine, or olanzapine + divalproex [valproate semisodium]) in the management of dementia with agitation: a pilot comparison of two standard therapies.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Nov 2013

At a glance

  • Drugs Olanzapine; Quetiapine; Risperidone; Valproate semisodium
  • Indications Dementia
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top